Consistency: Excellent across all four sources. Deep research, notes, review, PN and GOA all agree PELO is the eRF1-like ribosome-rescue factor (Pelota subfamily; no GGQ/peptidyl-tRNA hydrolase), subunit of the Pelota-HBS1L (Dom34-Hbs1) complex, working with HBS1L+ABCE1 to split stalled 80S and initiate NGD/NSD. No contradictions.
PN story / NEW pressure:GO:0072344 (verified real, rescue of stalled cytosolic ribosome) is already in GOA and in the review (IDA PMID:21448132, 27863242 + IBA) — fully captured. GO:0006515 (verified real) is new_to_goa; PELO genuinely drives stalled-ribosome QC, so it is a defensible higher-level process ADD, but it is broader than the review's already-precise GO:0072344/GO:0032790/GO:0070966/GO:0070481 set. Conclude: rescue already captured; GO:0006515 a defensible but redundant (broader) ADD.
Mapping strategy: Does not change the node. PN rescue-type→GO:0072344 exactly matches the review's core BP. The group→GO:0006515 propagation is broader than (a parent of) terms already annotated; per the TOMM20/HSPA8/RAB7A "rejected as broader" precedent it adds little. Status/scope (mapped, ok_for_propagation) are appropriate at the type level.
Evidence alignment: PN cites no PMIDs (row had none). Review evidence (21448132, 23667253, 27543824, 27863242) is fully self-consistent and HIGH/VERIFIED. No divergence to reconcile.
Verdict: Fully consistent; PN rescue mapping already captured exactly (GO:0072344), GO:0006515 is a defensible-but-broader ADD already entailed by finer terms. No YAML change needed.
Recommended edits: none required. [MAP] (optional) treat GO:0006515 for PELO as broader/redundant given GO:0072344 already exact in GOA+review.